BIOMAT Database Logo BIOMAT Database Logo

The mutant Eisai hyperbilirubinemic rat is resistant to bile acid-induced cholestasis and cytotoxicity. 1994

M Hoshino, and T Hayakawa, and A Hirano, and Y Kamiya, and T Ohiwa, and A Tanaka, and T Kumai, and T Inagaki, and M Miyaji, and T Takeuchi
First Department of Internal Medicine, Medical School, Nagoya City University, Japan.

We investigated bile flow and biliary excretion of bile acids in the Eisai hyperbilirubinemic rat, a Sprague-Dawley mutant rat with conjugated hyperbilirubinemia, using both in vivo and in vitro models. In vivo bile flow was lower in Eisai hyperbilirubinemic rats than in the control rats before and after taurocholate was infused. After taurocholate was infused, bile acid output was similar in the Eisai hyperbilirubinemic rats and control rats. In the isolated perfused rat liver, biliary excretion of bile acids was higher in the Eisai hyperbilirubinemic rats than in the control rats after a high-dose infusion of taurocholate (0.33 mumol/min/gm liver). Infusion of taurochenodeoxycholate (0.22 mumol/min/gm liver) did not produce cholestasis and did not reduce the biliary excretion of bile acids in the Eisai hyperbilirubinemic rats. Taurochenodeoxycholate significantly increased the phospholipid/bile acid molar ratio and slightly reduced bile acid-induced alkaline phosphatase output into bile. The release of lactate dehydrogenase from the perfused liver 30 min after the start of the taurochenodeoxycholate infusion was 10 times lower in the Eisai hyperbilirubinemic rats than in the control rats (2.0 +/- 0.8 vs. 28.7 +/- 6.8 mU/min/gm liver). When the isolated perfused rat liver was infused with a 1-min pulse of horseradish peroxidase (25 mg), we observed an early and late peak of biliary excretion of horseradish peroxidase. The Eisai hyperbilirubinemic rats showed a significant increase in the late peak.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007770 L-Lactate Dehydrogenase A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist. Lactate Dehydrogenase,Dehydrogenase, L-Lactate,Dehydrogenase, Lactate,L Lactate Dehydrogenase
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D011922 Rats, Mutant Strains Rats bearing mutant genes which are phenotypically expressed in the animals. Mutant Strains Rat,Mutant Strains Rats,Rat, Mutant Strains,Strains Rat, Mutant,Strains Rats, Mutant
D002779 Cholestasis Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS). Bile Duct Obstruction,Biliary Stasis,Bile Duct Obstructions,Biliary Stases,Cholestases,Duct Obstruction, Bile,Duct Obstructions, Bile,Obstruction, Bile Duct,Obstructions, Bile Duct,Stases, Biliary,Stasis, Biliary
D006735 Horseradish Peroxidase An enzyme isolated from horseradish which is able to act as an antigen. It is frequently used as a histochemical tracer for light and electron microscopy. Its antigenicity has permitted its use as a combined antigen and marker in experimental immunology. Alpha-Peroxidase,Ferrihorseradish Peroxidase,Horseradish Peroxidase II,Horseradish Peroxidase III,Alpha Peroxidase,II, Horseradish Peroxidase,III, Horseradish Peroxidase,Peroxidase II, Horseradish,Peroxidase III, Horseradish,Peroxidase, Ferrihorseradish,Peroxidase, Horseradish
D006932 Hyperbilirubinemia A condition characterized by an abnormal increase of BILIRUBIN in the blood, which may result in JAUNDICE. Bilirubin, a breakdown product of HEME, is normally excreted in the BILE or further catabolized before excretion in the urine. Bilirubinemia,Bilirubinemias,Hyperbilirubinemias
D000469 Alkaline Phosphatase An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M Hoshino, and T Hayakawa, and A Hirano, and Y Kamiya, and T Ohiwa, and A Tanaka, and T Kumai, and T Inagaki, and M Miyaji, and T Takeuchi
Decreased pancreatic exocrine function in the mutant Eisai hyperbilirubinemic rat (EHBR).
March 1999, Pancreas,
M Hoshino, and T Hayakawa, and A Hirano, and Y Kamiya, and T Ohiwa, and A Tanaka, and T Kumai, and T Inagaki, and M Miyaji, and T Takeuchi
Alterations in glutathione homeostasis in mutant Eisai hyperbilirubinemic rats.
July 1996, Hepatology (Baltimore, Md.),
M Hoshino, and T Hayakawa, and A Hirano, and Y Kamiya, and T Ohiwa, and A Tanaka, and T Kumai, and T Inagaki, and M Miyaji, and T Takeuchi
Canalicular transport of reduced glutathione in normal and mutant Eisai hyperbilirubinemic rats.
January 1992, The Journal of biological chemistry,
M Hoshino, and T Hayakawa, and A Hirano, and Y Kamiya, and T Ohiwa, and A Tanaka, and T Kumai, and T Inagaki, and M Miyaji, and T Takeuchi
Biliary excretion of bile acid conjugates in a hyperbilirubinemic mutant Sprague-Dawley rat.
August 1991, Hepatology (Baltimore, Md.),
M Hoshino, and T Hayakawa, and A Hirano, and Y Kamiya, and T Ohiwa, and A Tanaka, and T Kumai, and T Inagaki, and M Miyaji, and T Takeuchi
Hepatic uptake of bromosulfophthalein-glutathione in perfused Eisai hyperbilirubinemic mutant rat liver: a multiple-indicator dilution study.
February 1998, The Journal of pharmacology and experimental therapeutics,
M Hoshino, and T Hayakawa, and A Hirano, and Y Kamiya, and T Ohiwa, and A Tanaka, and T Kumai, and T Inagaki, and M Miyaji, and T Takeuchi
Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats.
June 1993, The Journal of pharmacology and experimental therapeutics,
M Hoshino, and T Hayakawa, and A Hirano, and Y Kamiya, and T Ohiwa, and A Tanaka, and T Kumai, and T Inagaki, and M Miyaji, and T Takeuchi
Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR).
March 1997, The Journal of pharmacology and experimental therapeutics,
M Hoshino, and T Hayakawa, and A Hirano, and Y Kamiya, and T Ohiwa, and A Tanaka, and T Kumai, and T Inagaki, and M Miyaji, and T Takeuchi
Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats.
October 1996, Biopharmaceutics & drug disposition,
M Hoshino, and T Hayakawa, and A Hirano, and Y Kamiya, and T Ohiwa, and A Tanaka, and T Kumai, and T Inagaki, and M Miyaji, and T Takeuchi
Treatment of hyperbilirubinemia in Eisai hyperbilirubinemic rat by transfecting human MRP2/ABCC2 gene.
April 2005, Pharmaceutical research,
M Hoshino, and T Hayakawa, and A Hirano, and Y Kamiya, and T Ohiwa, and A Tanaka, and T Kumai, and T Inagaki, and M Miyaji, and T Takeuchi
Improving effect of ethyl eicosapentanoate on statin-induced rhabdomyolysis in Eisai hyperbilirubinemic rats.
February 2006, Biochemical and biophysical research communications,
Copied contents to your clipboard!